MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/apt.15528

Медицинская библиотека · Alimentary pharmacology & therapeutics · 2019

Adverse events related to low dose corticosteroids in autoimmune hepatitis.

van den Brand Floris F, van der Veen Koen S, Lissenberg-Witte Birgit I, de Boer Ynto S, van Hoek Bart, Drenth Joost P H, Verdonk Robert C, Vrolijk Jan M, van Nieuwkerk Carin M J, Bouma Gerd, Dutch Autoimmune Hepatitis Study Group

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Autoimmune hepatitis requires long-term therapy, and systemic corticosteroids are the backbone of therapeutic management. Prolonged use of corticosteroids may lead to adverse events but data from long-term studies are mainly derived from studies in rheumatic diseases.

AIM: To assess cataract, diabetes and fractures in relation to corticosteroid doses in the long-term maintenance treatment of patients with autoimmune hepatitis.

METHODS

We retrospectively collected data on 476 patients (77% women) with an established diagnosis of autoimmune hepatitis. Binary logistic regression with a generalised estimating equation was used to analyse the association between current corticosteroid use and the incidence of cataract, diabetes and fractures with onset after autoimmune hepatitis diagnosis. We corrected for sex, age, cirrhosis at diagnosis and predniso(lo)ne use in the prior 3 years to account for possible ongoing effects.

RESULTS

A total of 6634 years, with a median of 13 (range 1-40) per patient were recorded. The median age at diagnosis was 44 years (range 2-88). Adverse events were documented in 120 (25%) patients. Low-dose predniso(lo)ne (0.1-5.0 mg/d) increased the odds of fractures whereas higher doses (>5.0 mg/d) increased the odds of cataracts and diabetes. Budesonide increased the odds of cataract and fractures; this effect was independent of predniso(lo)ne use in the prior 1, 2 or 3 years.

CONCLUSIONS

Even low doses of corticosteroids frequently lead to substantial adverse events refuting the assumption that adverse events are prevented by administering low doses.

Для цитирования: van den Brand Floris F, van der Veen Koen S, Lissenberg-Witte Birgit I, de Boer Ynto S, van Hoek Bart, Drenth Joost P H, Verdonk Robert C, Vrolijk Jan M, van Nieuwkerk Carin M J, Bouma Gerd, Dutch Autoimmune Hepatitis Study Group. Adverse events related to low dose corticosteroids in autoimmune hepatitis.. Alimentary pharmacology & therapeutics. 2019. DOI: 10.1111/apt.15528.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.